| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 10002707 | 105 | |||
| 10026678 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 16 | 105 |
| 10027736 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | S | 12 | 101 |
| 10027876 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 |
| 10034114 | SSSSAEHPGASKPPISSSSMTSR | S | 16 | 49 |
| 10037354 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | 101 | ||
| 10037545 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | 101 | ||
| 10037546 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | 105 | ||
| 10039141 | T | 105 | ||
| 10040937 | S | 101 | ||
| 10042040 | T | 105 | ||
| 10042205 | SSSSAEHPGASKPPISSSSMTSR | S | 16 | 49 |
| 10045475 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 16 | 105 |
| 10045801 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 |
| 10046273 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 |
| 10046920 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 10002707 | MS | HTP | unambiguous | human | HeLa cells | Mitotic exit/Early mitosis | None | 34161081 | The p value was -log10p in original paper. | |
| 10026678 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10027736 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10027876 | MS | HTP | unambiguous | human | HeLa cells | None | 35254053 | |||
| 10034114 | MS, site-directed mutagenesis | LTP | unambiguous | human | HEK 293T cells | None | 37886470 | |||
| 10037354 | MS | HTP | unambiguous | human | HEK 293T cells | TMG/control | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037545 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037546 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | None | 30620550 | Peptide quantification value was applied to each modification site | |
| 10039141 | MS | HTP | unambiguous | human | PANC-1 cells | None | 39302247 | |||
| 10040937 | MS | HTP | unambiguous | human | PANC-1 cells | None | 39531497 | |||
| 10042040 | MS | HTP | unambiguous | human | PANC-1 cells | None | 39531497 | |||
| 10042205 | MS, site-directed mutagenesis | LTP | unambiguous | human | HEK293T cells | None | 38961064 | |||
| 10045475 | MS | HTP | unambiguous | human | HeLa cells: nucleus | None | 39534244 | |||
| 10045801 | MS | HTP | unambiguous | human | HeLa cells: nucleus | None | 39534244 | |||
| 10046273 | MS | HTP | unambiguous | human | HeLa cells: cytoplasm | None | 39534244 | |||
| 10046920 | MS | HTP | unambiguous | human | HeLa cells: plasma membrane | None | 39534244 |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002707 | 105 | MS | HTP | unambiguous | human | HeLa cells | 34161081 | The p value was -log10p in original paper. | |||
| 10026678 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 16 | 105 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10027736 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | S | 12 | 101 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10027876 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10034114 | SSSSAEHPGASKPPISSSSMTSR | S | 16 | 49 | MS, site-directed mutagenesis | LTP | unambiguous | human | HEK 293T cells | 37886470 | |
| 10037354 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | 101 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037545 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | 101 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037546 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | 105 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10039141 | T | 105 | MS | HTP | unambiguous | human | PANC-1 cells | 39302247 | |||
| 10040937 | S | 101 | MS | HTP | unambiguous | human | PANC-1 cells | 39531497 | |||
| 10042040 | T | 105 | MS | HTP | unambiguous | human | PANC-1 cells | 39531497 | |||
| 10042205 | SSSSAEHPGASKPPISSSSMTSR | S | 16 | 49 | MS, site-directed mutagenesis | LTP | unambiguous | human | HEK293T cells | 38961064 | |
| 10045475 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 16 | 105 | MS | HTP | unambiguous | human | HeLa cells: nucleus | 39534244 | |
| 10045801 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 | MS | HTP | unambiguous | human | HeLa cells: nucleus | 39534244 | |
| 10046273 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 | MS | HTP | unambiguous | human | HeLa cells: cytoplasm | 39534244 | |
| 10046920 | VPVSQTPAINVSVPTTLPSATQVPMEVLK | T | 15 | 104 | MS | HTP | unambiguous | human | HeLa cells: plasma membrane | 39534244 |